These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 7856293

  • 1. Phase 1 trial of a 24-valent Klebsiella capsular polysaccharide vaccine and an eight-valent Pseudomonas O-polysaccharide conjugate vaccine administered simultaneously.
    Edelman R, Taylor DN, Wasserman SS, McClain JB, Cross AS, Sadoff JC, Que JU, Cryz SJ.
    Vaccine; 1994 Nov; 12(14):1288-94. PubMed ID: 7856293
    [Abstract] [Full Text] [Related]

  • 2. Immunogenicity of a 24-valent Klebsiella capsular polysaccharide vaccine and an eight-valent Pseudomonas O-polysaccharide conjugate vaccine administered to victims of acute trauma.
    Campbell WN, Hendrix E, Cryz S, Cross AS.
    Clin Infect Dis; 1996 Jul; 23(1):179-81. PubMed ID: 8816151
    [Abstract] [Full Text] [Related]

  • 3. Safety and immunogenicity of a polyvalent Pseudomonas aeruginosa O-polysaccharide-toxin A vaccine in humans.
    Cryz SJ, Sadoff JC, Cross AS, Fürer E.
    Antibiot Chemother (1971); 1989 Jul; 42():177-83. PubMed ID: 2512836
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A polyvalent Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine.
    Cryz SJ, Fürer E, Sadoff JC, Germanier R.
    Antibiot Chemother (1971); 1987 Jul; 39():249-55. PubMed ID: 3118786
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Safety and immunogenicity of a Pseudomonas aeruginosa O-polysaccharide toxin A conjugate vaccine in humans.
    Cryz SJ, Fürer E, Cross AS, Wegmann A, Germanier R, Sadoff JC.
    J Clin Invest; 1987 Jul; 80(1):51-6. PubMed ID: 3110215
    [Abstract] [Full Text] [Related]

  • 14. Human monoclonal antibodies to Pseudomonas aeruginosa type-specific lipopolysaccharides, toxin A and Klebsiella capsular polysaccharides.
    Lang AB, Fürer E, Schürch U, Cross AS, Larrick JW, Cryz SJ.
    Dev Biol Stand; 1990 Jul; 71():121-6. PubMed ID: 1698165
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Use of Pseudomonas aeruginosa toxin A in the construction of conjugate vaccines and immunotoxins.
    Cryz SJ, Fürer E, Sadoff JC, Germanier R, Pastan I, Willingham MC, FitzGerald DJ.
    Rev Infect Dis; 1987 Jul; 9 Suppl 5():S644-9. PubMed ID: 3120274
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.